Implantable-cardioverter defibrillators and COVID-19: A complicated relationship

Kardiol Pol. 2024;82(2):141-143. doi: 10.33963/v.phj.99380. Epub 2024 Feb 20.

Authors

Selcuk Adabag^{1

2}, Laith Alhuneafat^{3

4}

Affiliations

¹ Division of Cardiology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, United States. adaba001@umn.edu.
² Department of Medicine, University of Minnesota, Minneapolis, MN, United States. adaba001@umn.edu.
³ Division of Cardiology, Minneapolis Veterans Affairs Health Care System, Minneapolis, MN, United States.
⁴ Department of Medicine, University of Minnesota, Minneapolis, MN, United States.

PMID: 38374783
DOI: 10.33963/v.phj.99380

No abstract available

MeSH terms

COVID-19*
Defibrillators, Implantable* / adverse effects
Humans